Latest / The Prostate Health Podcast
69: PARP-Inhibitors: Entering a New Era of Personalized Treatment for Advanced Prostate Cancer - Emmanuel Antonarakis, MD
There is a continuous explosion of new and innovative therapies for men with advanced prostate cancer. Recently, two different PARP-Inhibitors were approved by the FDA for use. Those drugs were the first in their class to have been approved as personalized therapy for certain individuals with advanced prostate cancer.
Today, we have Dr. Emmanuel Antonarakis, a world-class expert in the area of targeted therapy for prostate cancer, joining us to talk about the two new medications and explain who might be eligible for that kind of therapy. Be sure to stay tuned for more!
Dr. Antonarakis is a…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.